Cell Rep (2023) 42:129
Data Extraction and Quality Assessment Two investigators (Hu and Song) independently extracted the following data by reviewing the full text of each study: first author, year of publication, Clinical Trial Registration Number (NCT ID), trial duration, patient characteristics, sample size, intervention (type of GLP-1 receptor agonist), comparators, and outcomes of interest
Ozempic is a drug that has received approval from the Food and Drug Administration (FDA) to lower blood sugar levels in adults suffering from type 2 diabetes
Heres a closer look at how Jardiance and Ozempic compare across key categories when you are considering them for weight loss
Cosmos Study May 16, 2024 Dual-Team Study Team A:Kersten Bartelt, RNBrendan Joyce Team B:Jeff Trinkl, MDJoe Deckert, PhD Key Findings Patients who lost less than 20 pounds on GLP-1 medications and were subsequently prescribed phentermine experienced greater weight loss while on phentermine in the year following GLP-1 treatment than patients who lost at least 20 pounds on the GLP-1 medication
& Klaper, R